Statistical Issues Including Design and Sample Size Calculation in Thorough QT/QTc StudiesFootnote∗

∗The opinions presented here do not necessarily represent those of the US Food and Drug Administration.

REFERENCES

• Berger , R. , Hsu , J. ( 1996 ). Bioequivalence trials, intersection-union tests and equivalence confidence sets . Statistical Science 11 : 283 – 319 .
   Web of Science ®Google Scholar
• Boos , D. , Hofffman , D. , Kringe , R. , Zhang , J. ( 2007 ). New confidence bounds for QT studies . Statistics in Medicine 26 : 3801 – 3817 .
   PubMed Web of Science ®Google Scholar
• Chen , L. , Tsong , Y. ( 2007 ). Design and analysis for drug abuse potential studies: Issues and strategies for implementing a crossover design . Drug Information Journal 41 : 481 – 489 .
   Web of Science ®Google Scholar
• Eaton , M. , Muirhead , R. , Mancuso , J. , Kolluri , S. ( 2006 ). A confidence interval for the maximal mean QT interval change caused by drug effect . Drug Information Journal 40 : 267 – 271 .
   Google Scholar
• Gould , A. L. ( 1992 ). Interim analyses for monitoring clinical trials that do not materially affect the Type I error rate . Statistics in Medicine 11 : 55 – 66 .
   PubMed Web of Science ®Google Scholar
• Gould , A. L. ( 1995 ). Planning and revising the sample size for a trial . Statistics in Medicine 14 : 1039 – 1051 .
   PubMed Web of Science ®Google Scholar
• Hochberg , H. , Tamhane , A. J. ( 1987 ). Multiple Comparison Procedures . John Wiley & Sons .
   Google Scholar
• ICH . ( 2005 ). ICH E14 Guidance. The Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Nonantiarrhythmic Drugs . International Conference on Harmonization , May 2005 , in Geneva, Swizterland .
   Google Scholar
• Jones , B. , Kenward , M. G. ( 2003 ). Design and Analysis of Cross-Over Trials. , 2nd ed. London : Chapman and Hall .
   Google Scholar
• Julious , S. A. ( 2004 ). Sample sizes for clinical trials with normal data . Statistics in Medicine 23 : 1921 – 1986 .
   PubMed Web of Science ®Google Scholar
• Kieser , M. , Friede , T. ( 2000 ). Recalculating the sample size in internal pilot study designs with control of the Type I error rate . Statistics in Medicine 19 : 901 – 911 .
   PubMed Web of Science ®Google Scholar
• Khongphatthanayothin , A. , Lane , J. , Thomas , D. , Yen , L. , Chang , D. , Bubolz , B. ( 1998 ). Effects of cisapride on QT interval in children . Journal of Pediatrics 133 : 51 – 56 .
   Google Scholar
• Lasser , K. E. , Allen , P. D. , Woolhandler , S. J. , Himmelstein , D. U. , Wolfe , S. M. , Bor , D. H. ( 2002 ). Timing of new black box warnings and withdrawals for prescription medications . The Journal of the American Medical Association 287 : 2215 – 2220 .
   PubMed Web of Science ®Google Scholar
• Luo , S. , Michler , K. , Johnston , P. , Macfarlane , P. W. ( 2004 ). A comparison of commonly used QT correction formulae: The effect of heart rate on the QTc of normal ECGs . Journal of Electrocardiology 37 ( Suppl ): 81 – 90 .
   PubMedGoogle Scholar
• Malik , M. , Farbom , P. , Batchvarov , V. , Hnatkova , K. , Camm , A. ( 2002 ). Relation between QT and RR intervals is highly individual among healthy subjects: Implications for heart rate correction of the QT interval . Heart 87 : 220 – 228 .
   PubMed Web of Science ®Google Scholar
• Patterson , S. , Agin , M. , Anziano , R. , Burgess , T. , Chuang-Stein , C. , Dmitrienko , A. , Ferber , G. , Francom , S. , Geraldes , M. , Ghosh , K. , Mills , T. , Menton , R. , Natarajan , J. , Offen , W. , Saoud , J. , Smith , B. , Suresh , R. , Zariffa , N. ( 2005 ). Investigating drug-induced QT and QTc prolongation in the clinic: Statistical design and analysis considerations . Drug Information Journal 39 : 243 – 266 .
   Web of Science ®Google Scholar
• Patterson , S. , Jones , B. ( 2006 ). Bioequivalence and Statistics in Clinical Pharmacology . Chapman & Hall/CRC .
   Google Scholar
• Pratt , C. M. , Hertz , R. P. , Ellis , B. E. , Crowell , S. P. , Louv , W. , Moye , L. ( 1994 ). Risk of developing life-threatening ventricular arrhythmia associated with tefenadine in comparison with over-the-counter antihistamines, ibuprofen and clemastine . American Journal of Cardiology 73 : 346 – 352 .
   PubMed Web of Science ®Google Scholar
• Shaffer , J. P. ( 1995 ). Multiple hypothesis testing . Ann. Rev. Psych 46 : 561 – 584 .
   Web of Science ®Google Scholar
• Welleck , S. ( 2003 ). Testing Statistical Hypotheses of Equivalence . London : Chapman and Hall .
   Google Scholar
• Westfall , P. H. , Tobias , R. D. , Rom , D. , Wolfinger , R. D. , Hochberg , Y. ( 1995 ). Multiple Comparisons and Multiple Tests Using the SAS System . SAS Institute .
   Google Scholar
• Williams , E. J. (1949). Experimental designs balanced for the estimation of residual effects of treatments. Australian Journal of Scientific Researc 2:149–168.
   Google Scholar
• Wysowski , D. K. , Corken , A. , Gallo-Torres , H. , Talarico , L. , Rodriguez , E. M. ( 2001 ). Postmarketing reports of QT prolongation and ventricular arrhythmia in association with cisapride and Food and Drug Administration regulatory actions . American Journal of Gastroenterology 96 : 1698 – 1703 .
   PubMed Web of Science ®Google Scholar
• Zhang , J. ( 2007 ). Design and statistical analysis of TQT studies . Presentation at DIA 43rd annual meeting , Atlanta , Georgia , June , 2007 .
   Google Scholar
• ∗The opinions presented here do not necessarily represent those of the US Food and Drug Administration.
   Google Scholar